Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry

Thrombosis Research

Volumn 124, Issue 4, 2009, Pages 418-422

  Lordkipanidzé, Marie ^a,b   Pharand, Chantal ^a,b   Schampaert, Erick ^a,b   Palisaitis, Donald A ^a,b   Diodati, Jean G ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Antiplatelet agents; Aspirin; Clopidogrel; Light transmission aggregometry; Platelet count drop; Platelet function testing

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG RESPONSE; FEMALE; GOLD STANDARD; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; AGED; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; TICLOPIDINE;

EID: 69249235773     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.02.002     Document Type: Article

References (32)

1. Patrono C., Baigent C., Hirsh J., and Roth G. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 199S-233S
2. Fraker Jr. T.D., Fihn S.D., Gibbons R.J., Abrams J., Chatterjee K., Daley J., et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina. Circulation 116 (2007) 2762-2772
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
4. Lordkipanidzé M., Pharand C., Palisaitis D.A., and Diodati J.G. Aspirin resistance : Truth or dare. Pharmacol Ther 112 (2006) 733-743
5. Nguyen T.A., Diodati J.G., and Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45 (2005) 1157-1164
6. Wenaweser P., Dorffler-Melly J., Imboden K., Windecker S., Togni M., Meier B., et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752
7. Cuisset T., Frere C., Quilici J., Barbou F., Morange P.E., Hovasse T., et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 4 (2006) 542-549
8. Gianetti J., Parri M.S., Sbrana S., Paoli F., Maffei S., Paradossi U., et al. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study. Thromb Res 118 (2006) 487-493
9. Foussas S.G., Zairis M.N., Patsourakos N.G., Makrygiannis S.S., Adamopoulou E.N., Handanis S.M., et al. The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting. Am Heart J 154 (2007) 676-681
10. Cuisset T., Hamilos M., Sarma J., Sarno G., Wyffels E., Vanderheyden M., et al. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol 101 (2008) 1700-1703
11. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 110 (2004) e489-e493
12. Harrison P. Progress in the assessment of platelet function. Br J Haematol 111 (2000) 733-744
13. Nicholson N., Panzer-Knodle S., Haas N., Taite B., Szalony J., Page J., et al. Assessment of platelet function assays. Am Heart J 135 (1998) S170-S178
14. Lordkipanidzé M., Pharand C., Nguyen T.A., Schampaert E., Palisaitis D.A., and Diodati J.G. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 29 (2008) 2877-2885
15. Lordkipanidzé M., Pharand C., Schampaert E., Turgeon J., Palisaitis D.A., and Diodati J.G. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28 (2007) 1702-1708
16. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., and Topol E.J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
17. Frere C., Cuisset T., Quilici J., Camoin L., Carvajal J., Morange P.E., et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 98 (2007) 838-843
18. Buonamici P., Marcucci R., Migliorini A., Gensini G.F., Santini A., Paniccia R., et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49 (2007) 2312-2317
19. Geisler T., Grass D., Bigalke B., Stellos K., Drosch T., Dietz K., et al. The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score. J Thromb Haemost 6 (2008) 54-61
20. Rand M.L., Leung R., and Packham M.A. Platelet function assays. Transfus Apher Sci 28 (2003) 307-317
21. Ryan W.L., Hakenkamp K., and Sullivan E. A new platelet function test. Thromb Res 58 (1990) 163-173
22. Lau W.C., Walker C.T., Obilby D., Wash M.M., Carville D.G., Guyer K.E., et al. Evaluation of a BED-SIDE Platelet Function Assay: Performance and Clinical Utility. Ann Card Anaesth 5 (2002) 33-42
23. ®: a novel point of care platelet function screen. Mol Diagn Ther 12 (2008) 253-258
24. Lennon M.J., Gibbs N.M., Weightman W.M., McGuire D., and Michalopoulos N. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth 18 (2004) 136-140
25. Mobley J.E., Bresee S.J., Wortham D.C., Craft R.M., Snider C.C., and Carroll R.C. Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol 93 (2004) 456-458
26. Craft R.M., Chavez J.J., Snider C.C., Muenchen R.A., and Carroll R.C. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 145 (2005) 309-315
27. Van Werkum J.W., Kleibeuker M., Postma S., Bouman H.J., Elsenbert E.H.A.M., Ten Berg J.M., et al. A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int J Cardiol (2008) 10.1016/j.ijcard.2008.10.046
28. Santos M.T., Valles J., Marcus A.J., Safier L.B., Broekman M.J., Islam N., et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87 (1991) 571-580
29. Valles J., Santos M.T., Aznar J., Osa A., Lago A., Cosin J., et al. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality : the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation 97 (1998) 350-355
30. Patrignani P. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res 110 (2003) 281-286
31. Heptinstall S., Johnson A., Glenn J.R., and White A.E. Adenine nucleotide metabolism in human blood-important roles for leukocytes and erythrocytes. J Thromb Haemost 3 (2005) 2331-2339
32. Dyszkiewicz-Korpanty A.M., Frenkel E.P., and Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 11 (2005) 25-35